VUZI Short Volume

Vuzix Corporation (VUZI) operates in the Technology sector, specifically the Consumer Electronics industry, with a market capitalization near $251.1M, listed on NASDAQ, employing roughly 76 people, carrying a beta of 1.52 to the broader market. Vuzix Corporation, together with its subsidiaries, designs, manufactures, markets, and sells augmented reality (AR) wearable display and computing devices for consumer and enterprise markets in North America, the Asia-Pacific, Europe, and internationally. Led by Paul J. Travers, public since 2010-04-05.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
679.5K
Total Volume
1.6M
Short %
41.31%
30-Day Avg Short %
42.70%

Showing 30 days of FINRA short volume data for Vuzix Corporation.

Learn how short volume is reported and how to read the data →

Frequently asked VUZI short volume questions

What is the daily VUZI short volume?
As of May 15, 2026, Vuzix Corporation (VUZI) short volume is 679.5K shares against 1.6M total reported volume, or 41.31% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is VUZI short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does VUZI short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.